Skip to content
  • EnglishEnglish
  • SvenskaSvenska
 

ASCELIA

AN ONCOLOGY-DEDICATED DRUG DEVELOPMENT COMPANY

  • About us
    • Management
    • Board of Directors
  • Diseases
    • Liver metastases
    • Gastric Cancer
  • Pipeline
    • Mangoral
    • Clinical Development Mangoral
    • Oncoral
    • Clinical Development Oncoral
  • IR & Media
    • Press releases & News
    • Reports & Presentations
    • Share
    • Shareholders
    • Equity research
    • Subscribe to press releases
    • Ascelia Pharma in Media
    • IR Contact
    • Financial calendar
    • Events
  • IPO
  • Corporate governance
    • General Meeting
    • AGM 2018
    • Articles of Association
    • Nomination Committee
    • Nomination Committee 2018
    • Board of Directors
    • Audit Committee
    • Remuneration Committee
    • Remuneration
    • Auditors
    • Internal control
  • Contact
  • Career

Financial reports

Annual report

Annual Report 2017-2018 FINAL (English version)

 

Interim report

  • Ascelia Pharma AB

  • Medeon Science Park

  • Per Albin Hanssons väg 41

  • 205 12 MALMÖ

  • Sweden

  • +46 735 179 110

Ascelia Pharma © 2019 | All Rights Reserved

Privacy policy Ascelia Pharma AB

We use cookies. Read more about cookies or read our Privacy Policy

Close